NCT07708402

Brief Summary

This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia. A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

11 months

First QC Date

July 7, 2026

Last Update Submit

July 10, 2026

Conditions

Keywords

schizophreniamix-method studyself-stigmanarrative therapy

Outcome Measures

Primary Outcomes (1)

  • The Internalized Stigma of Mental Illness Scale

    At baseline(T0) and through study completion, an average of 8 weeks

Secondary Outcomes (5)

  • Beck Depression Inventory-II

    At baseline(T0) and through study completion, an average of 8 weeks

  • Self-Reported Graphic version of the Personal and Social Performance Scale

    At baseline(T0) and through study completion, an average of 8 weeks

  • Subjective Happiness Scale

    At baseline(T0) and through study completion, an average of 8 weeks

  • Herth Hope Index

    At baseline(T0) and through study completion, an average of 8 weeks

  • The questionnaire about the process of recovery

    At baseline(T0) and through study completion, an average of 8 weeks

Study Arms (1)

Healing Stigma through Stories

EXPERIMENTAL
Other: Healing Stigma through Stories

Interventions

Four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.

Healing Stigma through Stories

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older.
  • Diagnosed with schizophrenia or schizoaffective disorder.
  • Clinically stable at the time of study enrollment.
  • Able to communicate in Mandarin Chinese or Taiwanese.
  • Able to read and write and complete study questionnaires.

You may not qualify if:

  • Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
  • Unwilling to have the intervention sessions audio-recorded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Central Study Contacts

Li-Ting Huang, phD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 16, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

July 16, 2026

Record last verified: 2026-07